Literature DB >> 32301620

Purinoceptors, renal microvascular function and hypertension.

Z Guan1, M N Makled, E W Inscho.   

Abstract

Proper renal blood flow (RBF) and glomerular filtration rate (GFR) are critical for maintaining normal blood pressure, kidney function and water and electrolyte homeostasis. The renal microvasculature expresses a multitude of receptors mediating vasodilation and vasoconstriction, which can influence glomerular blood flow and capillary pressure. Despite this, RBF and GFR remain quite stable when arterial pressure fluctuates because of the autoregulatory mechanism. ATP and adenosine participate in autoregulatory control of RBF and GFR via activation of two different purinoceptor families (P1 and P2). Purinoceptors are widely expressed in renal microvasculature and tubules. Emerging data show altered purinoceptor signaling in hypertension-associated kidney injury, diabetic nephropathy, sepsis, ischemia-reperfusion induced acute kidney injury and polycystic kidney disease. In this brief review, we highlight recent studies and new insights on purinoceptors regulating renal microvascular function and renal hemodynamics. We also address the mechanisms underlying renal microvascular injury and impaired renal autoregulation, focusing on purinoceptor signaling and hypertension-induced renal microvascular dysfunction. Interested readers are directed to several excellent and comprehensive reviews that recently covered the topics of renal autoregulation, and nucleotides in kidney function under physiological and pathophysiological conditions (Inscho 2009, Navar et al. 2008, Carlstrom et al. 2015, Vallon et al. 2020).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32301620      PMCID: PMC8006557          DOI: 10.33549/physiolres.934463

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  122 in total

1.  Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys.

Authors:  C M Chan; R J Unwin; M Bardini; I B Oglesby; A P Ford; A Townsend-Nicholson; G Burnstock
Journal:  Am J Physiol       Date:  1998-04

Review 2.  Concurrent activation of multiple vasoactive signaling pathways in vasoconstriction caused by tubuloglomerular feedback: a quantitative assessment.

Authors:  Jurgen Schnermann
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

3.  Altered whole kidney blood flow autoregulation in a mouse model of reduced beta-ENaC.

Authors:  Samira C Grifoni; Rumbidzayi Chiposi; Susan E McKey; Michael J Ryan; Heather A Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-04

4.  Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation.

Authors:  Zhengrong Guan; Barry S Fuller; Tatsuo Yamamoto; Anthony K Cook; Jennifer S Pollock; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-03

5.  Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients.

Authors:  P K Christensen; H P Hansen; H H Parving
Journal:  Kidney Int       Date:  1997-11       Impact factor: 10.612

6.  Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.

Authors:  Karen A Griffin; Maria M Picken; Anil K Bidani
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

7.  Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models.

Authors:  Oliver Vonend; Clare M Turner; Choong M Chan; Andrew Loesch; G Carmen Dell'Anna; Kaila S Srai; Geoffrey Burnstock; Robert J Unwin
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

8.  Effects of ATP on pre- and postglomerular juxtamedullary microvasculature.

Authors:  E W Inscho; K Ohishi; L G Navar
Journal:  Am J Physiol       Date:  1992-11

9.  ATP as a mediator of macula densa cell signalling.

Authors:  P Darwin Bell; Peter Komlosi; Zhi-Ren Zhang
Journal:  Purinergic Signal       Date:  2009-03-28       Impact factor: 3.765

10.  Avian erythroblastosis virus E26 oncogene homolog-1 (ETS-1) plays a role in renal microvascular pathophysiology in the Dahl salt-sensitive rat.

Authors:  Wenguang Feng; Zhengrong Guan; Dongqi Xing; Xingsheng Li; Wei-Zhong Ying; Colton E Remedies; Edward W Inscho; Paul W Sanders
Journal:  Kidney Int       Date:  2019-10-22       Impact factor: 10.612

View more
  6 in total

Review 1.  Purinoceptor: a novel target for hypertension.

Authors:  Xuan Li; Li-Juan Zhu; Jing Lv; Xin Cao
Journal:  Purinergic Signal       Date:  2022-02-18       Impact factor: 3.765

2.  TRPM7 promotes lipopolysaccharide-induced inflammatory dysfunction in renal tubular epithelial cells.

Authors:  Yan Sun; Xiaobing Chen; Yongpeng Xie; Yanli Wang; Qian Zhang; Yu Lu; Xiaomin Li
Journal:  Immun Inflamm Dis       Date:  2022-07

3.  Restoration of afferent arteriolar autoregulatory behavior in ischemia-reperfusion injury in rat kidneys.

Authors:  Wenguang Feng; Colton E Remedies; Ijeoma E Obi; Stephen R Aldous; Samia I Meera; Paul W Sanders; Edward W Inscho; Zhengrong Guan
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-25

4.  Decreased parenchymal arteriolar tone uncouples vessel-to-neuronal communication in a mouse model of vascular cognitive impairment.

Authors:  Ki Jung Kim; Juan Ramiro Diaz; Jessica L Presa; P Robinson Muller; Michael W Brands; Mohammad B Khan; David C Hess; Ferdinand Althammer; Javier E Stern; Jessica A Filosa
Journal:  Geroscience       Date:  2021-01-07       Impact factor: 7.713

5.  Induction of renal tumor necrosis factor-α and other autacoids and the beneficial effects of hypertonic saline in acute decompensated heart failure.

Authors:  Stergios Gatzoflias; Shoujin Hao; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2021-05-10

6.  Mechanism of herbal medicine on hypertensive nephropathy (Review).

Authors:  Zhaocheng Dong; Haoran Dai; Zhandong Feng; Wenbin Liu; Yu Gao; Fei Liu; Zihan Zhang; Na Zhang; Xuan Dong; Qihan Zhao; Xiaoshan Zhou; Jieli Du; Baoli Liu
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.